HOME › DRUGS › IBUPROFEN LYSINE
ACTIVE SUBSTANCE / INN

IBUPROFEN LYSINE

Brand name(s): NEOPROFEN, IBUPROFEN LYSINE
FDA LISTED
PRESCRIPTION
ANDA202402
NDA021903
ACTIVE SUBSTANCE
Ibuprofen Lysine
REGULATORS
FDA
SPONSORS / MAH
RECORDATI RARE, XGEN PHARMS
TOTAL APPLICATIONS
2
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
IBUPROFEN LYSINEANDA202402XGEN PHARMSPrescription
NEOPROFENNDA021903RECORDATI RAREPrescription

FULL INTELLIGENCE ON IBUPROFEN LYSINE

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →